Re-charter of the Natonal Vaccine Advisory Committee, 48864-48865 [2011-20197]
Download as PDF
<![CDATA[
48864
Federal Register / Vol. 76, No. 153 / Tuesday, August 9, 2011 / Notices
charter also can be obtained by
accessing the FACA database that is
maintained by the Committee
Management Secretariat under the
General Services Administration. The
Web site address for the FACA database
is https://www.fido.gov/facadatabase.
Christopher H. Bates.
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2011–20230 Filed 8–8–11; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Department of Health and
Human Services, Office of the Assistant
Secretary for Health, Presidential
Commission for the Study of Bioethical
Issues.
ACTION: Notice of meeting.
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues will
conduct its sixth meeting in August. At
this meeting, the Commission will
discuss research into the U.S. Public
Health Service STD inoculation and
serological studies in Guatemala from
1946–1948, and the current Federal
standards regarding human subjects
protection in scientific studies.
DATES: The meeting will take place
Monday and Tuesday, August 29 and
30, 2011.
ADDRESSES: The Ritz-Carlton Hotel,
1150 22nd Street, NW., Washington, DC
20037. Phone 202–835–0500.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, Presidential Commission for
the Study of Bioethical Issues, 1425
New York Avenue, NW., Suite C–100,
Washington, DC 20005. Telephone:
202–233–3960. E-mail:
Hillary.Viers@bioethics.gov. Additional
information may be obtained at https://
www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
sixth meeting of the Presidential
Commission for the Study of Bioethical
Issues (the Commission). The meeting
will be held from 10 a.m. to
approximately 4 p.m. on Monday,
August 29, 2011, and from 9 a.m. to
approximately 4 p.m. on Tuesday,
August 30, 2011, in Washington, DC.
The meeting will be open to the public
with attendance limited to space
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:06 Aug 08, 2011
Jkt 223001
available. The meeting will also be
webcast at https://www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an advisory panel of
the nation’s leaders in medicine,
science, ethics, religion, law, and
engineering. The Commission advised
the President on bioethical issues
arising from advances in biomedicine
and related areas of science and
technology. The Commission seeks to
identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda items for this sixth
meeting are to review Public Health
Service STD inoculation and serological
studies in the 1940s in Guatemala as
well as contemporary Federal standards
for human subjects protections in
scientific studies supported by the
Federal government as requested by
President Obama on November 24,
2010.
The draft meeting agenda and other
information about PCSBI, including
information about access to the webcast,
will be available at https://
www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful debate of opposing views
and active participants by citizens in
public exchange of ideas can enhance
decisions that are reached and the
overall public understanding of them.
The Commission is particularly
interested in receiving oral comments
during the meeting that are responsive
to specific sessions. Written comments
will be accepted at the registration desk
and comment forms will be provided for
members of the public to write down
questions for the Commission as they
arise. To accommodate as many
speakers as possible the time for each
individual to speak may be limited. If
the number of individuals wishing to
speak is greater than can reasonably be
accommodated during the scheduled
meeting, the Commission may randomly
select comments.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo (contact
information above) in advance of the
meeting. The Commission will make
every effort to accommodate persons
who need special assistance.
Written comments will also be
accepted and are especially welcome.
Please address written comments by e-
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
mail to info@bioethics.gov, or by mail to
the following address: Public
Commentary, Presidential Commission
for the Study of Bioethical Issues, 1425
New York Ave., NW., Suite C–100,
Washington, DC 20005. Comments will
be publicly available, including any
personally identifiable or confidential
business information that they contain.
Trade secrets should not be submitted.
Dated: July 29, 2011.
Valerie H. Bonham,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2011–20195 Filed 8–8–11; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Re-charter of the Natonal Vaccine
Advisory Committee
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health, National Vaccine Program
Office.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) has been
rechartered.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
LCDR Guillermo Aviles-Mendoza,
Public Health Advisor, National Vaccine
Program Office, Department of Health
and Human Services, Room 739G.4
Hubert H. Humphrey Building, 200
Independence Avenue, SW.,
Washington, DC 20201. Phone: (202)
205–2982; Fax: (202) 690–4631; e-mail:
nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: NVAC is a
non-discretionary Federal advisory
committee. The establishment of NVAC
was mandated under Section 2105 (42
U.S.C. Section 300aa-5) of the Public
Health Service (PHS) Act, as amended.
NVAC advises and makes
recommendations to the Director,
National Vaccine Program (NVP), on
matters related to the Program’s
responsibilities. The Assistant Secretary
for Health is appointed to serve as the
Director, NVP.
To carry out its mission, NVAC (1)
studies and recommends ways to
encourage the availability of an
adequate supply of safe and effective
vaccination products in the United
States; (2) recommends research
priorities and other measures the
Director of the NVP should take to
enhance the safety and efficacy of
E:\FR\FM\09AUN1.SGM
09AUN1
48865
Federal Register / Vol. 76, No. 153 / Tuesday, August 9, 2011 / Notices
vaccines; (3) advises the Director of the
NVP in the implementation of Sections
2102 and 2103 of the PHS Act; and (4)
identifies annually for the Director of
the NVP the most important areas of
governmental and non-governmental
cooperation that should be considered
in implementing Sections 2101 and
2103 of the PHS Act.
NVAC was established on July 30,
1987. As a Federal advisory committee,
NVAC is governed by the provisions of
the Federal Advisory Committee Act,
Public Law 92–463, as amended (5
U.S.C. App.) To comply with the
guidelines under FACA, NVAC has been
re-chartered at the appropriate intervals
since it was established. On July 27,
2011, the Assistant Secretary for Health
approved for NVAC to be rechartered.
The new charter was effected and filed
with the appropriate Congressional
offices and Library of Congress on July
30, 2011. The rechartering of NVAC
gives authorization for the Committee to
continue to operate until July 30, 2013.
A copy of the NVAC charter is
available on the website for the National
Vaccine Program Office at https://
www.hhs.gov/nvpo/nvac. A copy of the
charter also can be obtained by
accessing the FACA database that is
maintained by the Committee
Management Secretariat under the
General Services Administration. The
website address for the FACA database
is https://fido.gov/facadatabase.
Bruce Gellin,
Deputy Assistant Secretary for Health
(Vaccines and Immunization), Director,
National Vaccine Program Office.
[FR Doc. 2011–20197 Filed 8–8–11; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: The OCSE–157 Child Support
Enforcement Annual Data Report.
Number of
respondents
Instrument
sroberts on DSK5SPTVN1PROD with NOTICES
OCSE–157 Child Support Annual Data Report ...............................................
Estimated Total Annual Burden
Hours: 378.
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7285,
E-mail:
OIRA_SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
VerDate Mar<15>2010
19:06 Aug 08, 2011
Jkt 223001
Robert Sargis
Reports Clearance Officer.
[FR Doc. 2011–20105 Filed 8–8–11; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Tribal Consultation Meetings
Administration for Children
and Families’ Office of Head Start
(OHS).
ACTION: Notice of meetings.
AGENCY:
Pursuant to the Improving
Head Start for School Readiness Act of
2007, Public Law 110–134, notice is
hereby given of one-day Tribal
Consultation Sessions to be held
between the Department of Health and
Human Services, Administration for
Children and Families, Office of Head
Start leadership and the leadership of
Tribal Governments operating Head
Start (including Early Head Start)
programs. The purpose of these
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
54
Administration for Children and
Families.
SUMMARY:
OMB No.: 0970–0177.
Description: The information obtained
from this form will be used to: (1)
Report Child Support Enforcement
activities to the Congress as required by
law; (2) calculate incentive measures
performance and performance
indicators utilized in the program; and
(3) assist the Office of Child Support
Enforcement (OCSE) in monitoring and
evaluating State Child Support
programs. OCSE is proposing minor
changes to the OCSE–157 report
instructions for medical support line
items that will provide states with the
option to define medical support to
include private health insurance as well
as other health care coverage such as
Medicaid, Children’s Health Insurance
Program (CHIP) and other state coverage
plans, and cash medical support.
Further legislative or regulatory changes
may be necessary to update medical
child support policy.
Respondents: State, Local or Tribal
Government.
Annual Burden Estimates.
1
Average
burden hours
per response
Total burden
hours
7
378
Consultation Sessions is to discuss ways
to better meet the needs of American
Indian and Alaska Native children and
their families, taking into consideration
funding allocations, distribution
formulas, and other issues affecting the
delivery of Head Start services in their
geographic locations [42 U.S.C. 9835,
Section 640(l)(4)].
DATES: October 17 and 19, 2011.
ADDRESSES: 2011 Office of Head Start
Tribal Consultation Sessions will be
held at the following locations: Monday,
October 17, 2011— Seattle,
Washington—Westin Seattle,1900 5th
Avenue, Seattle, WA 98101;
Wednesday, October 19, 2011—
Anchorage, Alaska—Sheraton
Anchorage Hotel & Spa, 401 East 6th
Avenue, Anchorage, AK 99501.
FOR FURTHER INFORMATION CONTACT:
Camille Loya, Acting Regional Program
Manager Region XI, e-mail
Camille.Loya@acf.hhs.gov or phone
(202) 401–5964. Additional information
and online meeting registration is
available at https://
www.headstartresourcecenter.org.
The
Department of Health and Human
Services (HHS) announces Office of
Head Start (OHS) Tribal Consultations
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09AUN1.SGM
09AUN1
]]>Agencies
[Federal Register Volume 76, Number 153 (Tuesday, August 9, 2011)]
[Notices]
[Pages 48864-48865]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-20197]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Re-charter of the Natonal Vaccine Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health, National
Vaccine Program Office.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services is hereby giving
notice that the National Vaccine Advisory Committee (NVAC) has been
rechartered.
FOR FURTHER INFORMATION CONTACT: LCDR Guillermo Aviles-Mendoza, Public
Health Advisor, National Vaccine Program Office, Department of Health
and Human Services, Room 739G.4 Hubert H. Humphrey Building, 200
Independence Avenue, SW., Washington, DC 20201. Phone: (202) 205-2982;
Fax: (202) 690-4631; e-mail: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: NVAC is a non-discretionary Federal advisory
committee. The establishment of NVAC was mandated under Section 2105
(42 U.S.C. Section 300aa-5) of the Public Health Service (PHS) Act, as
amended. NVAC advises and makes recommendations to the Director,
National Vaccine Program (NVP), on matters related to the Program's
responsibilities. The Assistant Secretary for Health is appointed to
serve as the Director, NVP.
To carry out its mission, NVAC (1) studies and recommends ways to
encourage the availability of an adequate supply of safe and effective
vaccination products in the United States; (2) recommends research
priorities and other measures the Director of the NVP should take to
enhance the safety and efficacy of
[[Page 48865]]
vaccines; (3) advises the Director of the NVP in the implementation of
Sections 2102 and 2103 of the PHS Act; and (4) identifies annually for
the Director of the NVP the most important areas of governmental and
non-governmental cooperation that should be considered in implementing
Sections 2101 and 2103 of the PHS Act.
NVAC was established on July 30, 1987. As a Federal advisory
committee, NVAC is governed by the provisions of the Federal Advisory
Committee Act, Public Law 92-463, as amended (5 U.S.C. App.) To comply
with the guidelines under FACA, NVAC has been re-chartered at the
appropriate intervals since it was established. On July 27, 2011, the
Assistant Secretary for Health approved for NVAC to be rechartered. The
new charter was effected and filed with the appropriate Congressional
offices and Library of Congress on July 30, 2011. The rechartering of
NVAC gives authorization for the Committee to continue to operate until
July 30, 2013.
A copy of the NVAC charter is available on the website for the
National Vaccine Program Office at https://www.hhs.gov/nvpo/nvac. A copy
of the charter also can be obtained by accessing the FACA database that
is maintained by the Committee Management Secretariat under the General
Services Administration. The website address for the FACA database is
https://fido.gov/facadatabase.
Bruce Gellin,
Deputy Assistant Secretary for Health (Vaccines and Immunization),
Director, National Vaccine Program Office.
[FR Doc. 2011-20197 Filed 8-8-11; 8:45 am]
BILLING CODE 4150-44-P
